Recent research achievements from the Giessen lab.

A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.

Survey shows many teens and young adults support making menstrual products more accessible to fight "period poverty."

Dr. Meredith Skiba will join the faculty of the Departments of Biological Chemistry and Pharmacology at U-M Medical School in 2025.

A new collaborative study, examined the interaction between three naturally occurring gases — nitric oxide (NO), oxygen, and H2S — during generation of new blood vessels, called angiogenesis.

The Giessen lab publishes a research article in Nature Communications.

An article about a program to promote faculty diversity co-authored by Ruma Banerjee and two research articles by Banerjee lab members and their U-M collaborators have come into view this week.

Many women don’t get cervical cancer screening such as Pap tests, or don’t go for follow up diagnostic tests; a new study shows what could happen if all of them did.

Patients can now enroll in a clinical trial to test a groundbreaking nonsurgical treatment for cervical lesions that affect nearly 300,000 women in the United States every year.

Assistant Professor Yan Zhang of the Department of Biological Chemistry at U-M Medical School is the recipient of an NSF CAREER award.

PhD student Basila Moochickal Assainar is the first author of a research article in Nature Communications.

Lung disease specialist comes to Michigan from Vanderbilt University School of Medicine to lead largest department

Elective surgery study shows older adults have concerns about what it will cost them, how much work they’ll miss and whether they’ll catch COVID-19.

A study from the University of Michigan Medical School developed off-switches useful for improving the safety of the Type I-C/Cas3 gene editor.

PhD student Mason Myers of the Zhang lab at U-M Medical School is a lead author of "Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications."